These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 11847188)
1. Angiotensinogen and its cleaved derivatives inhibit angiogenesis. Célérier J; Cruz A; Lamandé N; Gasc JM; Corvol P Hypertension; 2002 Feb; 39(2):224-8. PubMed ID: 11847188 [TBL] [Abstract][Full Text] [Related]
2. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors. Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903 [TBL] [Abstract][Full Text] [Related]
3. Goniodomin A, an antifungal polyether macrolide, exhibits antiangiogenic activities via inhibition of actin reorganization in endothelial cells. Abe M; Inoue D; Matsunaga K; Ohizumi Y; Ueda H; Asano T; Murakami M; Sato Y J Cell Physiol; 2002 Jan; 190(1):109-16. PubMed ID: 11807817 [TBL] [Abstract][Full Text] [Related]
4. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. Bråkenhielm E; Cao R; Cao Y FASEB J; 2001 Aug; 15(10):1798-800. PubMed ID: 11481234 [No Abstract] [Full Text] [Related]
5. Inhibition of angiogenesis: a new function for angiotensinogen and des(angiotensin I)angiotensinogen. Corvol P; Lamandé N; Cruz A; Celerier J; Gasc JM Curr Hypertens Rep; 2003 Apr; 5(2):149-54. PubMed ID: 12642015 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist. Kumar CC; Malkowski M; Yin Z; Tanghetti E; Yaremko B; Nechuta T; Varner J; Liu M; Smith EM; Neustadt B; Presta M; Armstrong L Cancer Res; 2001 Mar; 61(5):2232-8. PubMed ID: 11280792 [TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells. Larsson H; Sjöblom T; Dixelius J; Ostman A; Ylinenjärvi K; Björk I; Claesson-Welsh L Cancer Res; 2000 Dec; 60(23):6723-9. PubMed ID: 11118058 [TBL] [Abstract][Full Text] [Related]
9. Angiogenic activity of pyruvic acid in in vivo and in vitro angiogenesis models. Lee MS; Moon EJ; Lee SW; Kim MS; Kim KW; Kim YJ Cancer Res; 2001 Apr; 61(8):3290-3. PubMed ID: 11309282 [TBL] [Abstract][Full Text] [Related]
10. Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. Seandel M; Noack-Kunnmann K; Zhu D; Aimes RT; Quigley JP Blood; 2001 Apr; 97(8):2323-32. PubMed ID: 11290594 [TBL] [Abstract][Full Text] [Related]
11. Characterization of human chorionic gonadotropin as a novel angiogenic factor. Zygmunt M; Herr F; Keller-Schoenwetter S; Kunzi-Rapp K; Münstedt K; Rao CV; Lang U; Preissner KT J Clin Endocrinol Metab; 2002 Nov; 87(11):5290-6. PubMed ID: 12414904 [TBL] [Abstract][Full Text] [Related]
12. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Wilting J; Christ B; Bokeloh M; Weich HA Cell Tissue Res; 1993 Oct; 274(1):163-72. PubMed ID: 7694800 [TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic activity of the purine analog 6-thioguanine. Presta M; Belleri M; Vacca A; Ribatti D Leukemia; 2002 Aug; 16(8):1490-9. PubMed ID: 12145690 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Anand-Apte B; Pepper MS; Voest E; Montesano R; Olsen B; Murphy G; Apte SS; Zetter B Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):817-23. PubMed ID: 9112976 [TBL] [Abstract][Full Text] [Related]
15. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF. Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784 [TBL] [Abstract][Full Text] [Related]
16. Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: endothelial fenestration and angiogenesis. Ribatti D; Nico B; Morbidelli L; Donnini S; Ziche M; Vacca A; Roncali L; Presta M J Vasc Res; 2001; 38(4):389-97. PubMed ID: 11455210 [TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge. Rodríguez-Nieto S; González-Iriarte M; Carmona R; Muñoz-Chápuli R; Medina MA; Quesada AR FASEB J; 2002 Feb; 16(2):261-3. PubMed ID: 11772945 [TBL] [Abstract][Full Text] [Related]
18. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. Scapini P; Nesi L; Morini M; Tanghetti E; Belleri M; Noonan D; Presta M; Albini A; Cassatella MA J Immunol; 2002 Jun; 168(11):5798-804. PubMed ID: 12023382 [TBL] [Abstract][Full Text] [Related]
19. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Clapp C; Martial JA; Guzman RC; Rentier-Delure F; Weiner RI Endocrinology; 1993 Sep; 133(3):1292-9. PubMed ID: 7689950 [TBL] [Abstract][Full Text] [Related]
20. VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane. Wilting J; Birkenhäger R; Eichmann A; Kurz H; Martiny-Baron G; Marmé D; McCarthy JE; Christ B; Weich HA Dev Biol; 1996 May; 176(1):76-85. PubMed ID: 8654896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]